摘要
【目的】观察舒利迭对哮喘缓解期患儿肺功能的影响及其安全性。【方法】将本院2009年10月至2010年2月收治的50例哮喘缓解期患几随机分为对照纽24例和观察纽26例，对照纽采用丙酸氟替卡松治疗，观察组采用舒利迭治疗，比较分析两组患者肺功能情况及不良反应发生情况。【结果】观察组患儿的肺功能各指标均优于对照组，组间差异有显著性（P〈0．05）；两组均无明显不良反应发生。【结论】舒利迭治疗哮喘缓解期患儿能够提高肺功能，且无明显不良反应，值得临床推广应用。
[Objective]To observe the effect and safety of seretide on lung function of children with asthma in remission stage. [Methods] From October 2009 to February 2010 in our hospital, 50 children with asthma in remission stage were randomly divided into control group（n=24） and observation group（n= 26）. The con trol group was treated with floticasone propionate, and the observation group was treated with seretide. Lung function and the incidence of side effects of two groups were compared and analyzed. [Results] Lung function in children of the observation group were better than the control group, and the differences were statistically significant between two groups（ P 〈0.05）. There were no significant side effects in two groups. [Conclusion] Seretide for the treatment of children with asthma in remission stage can improve lung function and has no obvious adverse reactions, so it is worthy of be spread and applied in clinic.
出处
《医学临床研究》
CAS
2011年第1期117-118,共2页
Journal of Clinical Research
